4551.T लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:45):

Stats
आज की मात्रा	48 200.00
औसत मात्रा	31 521.00
बाजार मूल्य	108.35B
EPS	¥0 ( 2024-04-25 )
Last Dividend	¥50.00 ( 2023-06-29 )
Next Dividend	¥0 ( N/A )
P/E	26.32
ATR14	¥5.18 (0.13%)

मात्रा सहसंबंध

लंबा: 0.15 (neutral)

छोटा: 0.40 (neutral)

Signal:(54.642) Neutral

Torii Pharmaceutical Co., सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Torii Pharmaceutical Co., सहसंबंध - मुद्रा/वस्त्र

0.94
( very strong )

0.65
( weak )

0.86
( strong )

-0.78
( moderate negative )

-0.87
( strong negative )

Torii Pharmaceutical Co., वित्तीय

Annual	2023
राजस्व:	¥54.64B
सकल लाभ:	¥24.57B (44.97 %)
EPS:	¥146.57

FY	2023
राजस्व:	¥54.64B
सकल लाभ:	¥24.57B (44.97 %)
EPS:	¥146.57

FY	2022
राजस्व:	¥48.89B
सकल लाभ:	¥23.38B (47.81 %)
EPS:	¥140.38

FY	2021
राजस्व:	¥46.99B
सकल लाभ:	¥24.34B (51.80 %)
EPS:	¥32.16

Financial Reports:

No articles found.

Torii Pharmaceutical Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥76.00 (N/A)	¥0 (N/A)	¥50.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Torii Pharmaceutical Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 7.39 - good (73.87%) | Divividend Growth Potential Score: 3.44 - Decrease likely (31.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥2.00	2001-03-27
Last Dividend	¥50.00	2023-06-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	47	--
Total Paid Out	¥907.00	--
Avg. Dividend % Per Year	0.00%	--
Score	3.09	--
Div. Sustainability Score	7.39
Div.Growth Potential Score	3.44
Div. Directional Score	5.41	--

Next Divdend (Est)
(2024-09-25)

¥0 Estimate 3.76 %

Dividend Stability

0.30 Poor

Dividend Score

3.09

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3292.T	Ex Dividend Knight	2024-01-30	Semi-Annually	0.00%
2359.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
9303.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8031.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7278.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6516.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
5757.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
4540.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3762.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3030.T	Ex Dividend Junior	2024-02-28	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0939	1.500	8.12	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0398	1.200	8.67	10.00	[0 - 0.3]
returnOnEquityTTM	0.0444	1.500	-0.618	-0.927	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	6.50	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.20	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.280	1.500	9.56	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.448	1.000	5.86	5.86	[0.2 - 0.8]
operatingProfitMarginTTM	0.122	1.000	9.56	9.56	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.423	0.800	-0.511	-0.409	[0.5 - 2]
Total Score				7.39

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.50	1.000	8.03	0	[1 - 100]
returnOnEquityTTM	0.0444	2.50	-0.397	-0.927	[0.1 - 1.5]
freeCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	3.11	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.448	1.500	-0.349	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0163	1.000	-2.09	0	[0.1 - 0.5]
Total Score				3.44

Torii Pharmaceutical Co.,

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.